Metastatic Papillary Renal Cell Carcinoma
4 clinical trials · Condition
◉ Watch Metastatic Papillary Renal Cell Carcinoma
| Record | Firm | Date |
|---|---|---|
| CBM588 in Combination With Nivolumab and Cabozantinib for the Treatment of Advanced or Metastatic Kidney Cancer (NCT05122546) | City of Hope Medical Center | 2021-11-01 |
| Testing Cabozantinib, Crizotinib, Savolitinib and Sunitinib in Kidney Cancer Which Has Progressed (NCT02761057) | National Cancer Institute (NCI) | 2016-07-25 |
Track Metastatic Papillary Renal Cell Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.